Q: This is more an observation rather than a question. On January 10th 2020 the Wall street Journal had a piece on the harmful practice of flaring natural gas. It referred to only one company and that was Questor. The CEO was referred to twice and also quoted.
Q: What is your opinion about this stock? I've been told it's a well managed company, but the stock price seems to be heading downward lately in a continuing bull market. Has this got anything to do with a recent acquisition which was not liked by an analyst? Or, a change on growth prospects? Someone dumping their position?Thanks for your opinion.
Q: Hi Peter, I’m very interested in this company. I’ve done my dd on it. New ceo last September who seems to be surrounding herself with experts from her past. The technology seems great!
Could you give me any info you have and your opinion as to a buy with small cap risk.
Thanks as always.
DS
Q: Hello Peter and Team,
Wondering if you think this may be a good entry point for an investment in Greenbrook TMS. The company claims that its electromagnetic treatment for clinical depression is 68% effective with no significant side effects. This would make it more effective than any single depression drug on the market. With depression being so prevalent and insurance companies looking to save LTD payouts, it seems likely that the popularity of this treatment modality could quickly become widespread. Although it may be an effective treatment, what do you think of the company’s business model?
Thank you.
Brad
Q: On several occasions when responding to questions about WELL you mention risk - an excellent point as it is a relatively small company.
But in comparison to many other smaller companies there are important aspects that in my mind mitigate the risk somewhat. For example:
- the quality and reputation of management and its obvious ability to attract investors
- founded first and foremost on the ownership of health clinics (relatively stable recurring revenue, insulated somewhat from recessions)
- disciplined/focused in its choice of foundational corporate software platform (i.e. OSCAR). OSCAR is open source and free of royalties - think of RedHat's success. OSCAR is its singular software focus - think Westjet and the cost savings by limiting maintenance to only one type of aircraft. And then the cost/effort when it comes to adding new functionality (e.g. telemedicine) to your product like all software products must do.
None of this guarantees unqualified success in the marketplace of course but what additional risks should an investor in WELL consider? Thank you.
Q: How significant is the Flyht Aerospace Solutions Ltd (FLY-X) announcement this morning of a 5 year agreement ($6.2M) with Westjet who will install Flyht's automated flight information reporting system in more than 160 planes? Thanks
Q: Hi, Could you please comment on Sylogist results. How did company perform, if one time item of executive bonuses is taken off the results ? They commented on company's efforts in M&A and current elevated valuations. What are your thoughts ? Thanks
Q: Just heard about this promising bioscience company on the local newscast. Your initial thoughts /analysis for a small position in a growth portfolio with a long timeframe? Thanx!
I've held MCR since the highs of 2014 and have been patient - very patient. But I'm wondering now whether I should sell at a loss and re-deploy the cash. It's a small position that I'm left with and I'm still generally over-weight the energy sector.
Q: I am considering adding one or two of the above stocks to my TFSA. I am looking for a growth company. If you could give me two suggestions either from my list or if you have a choice of your own that may have better potential. Of the ones that you choose could you elaborate on why they would be a good choice in the TFSA.
I really appreciate your advice in this question section. It has help me on many occasions in making a better informed decision when purchasing the stock.
Thank you again.
John